Steris (STE) Cash from Financing Activities (2018 - 2026)

Steris (STE) recorded quarterly Cash from Financing Activities of -$97.9 million in Q1 2026, little changed quarter-over-quarter from -$98.0 million in Q4 2025, and up 45.03% on a YoY basis from -$67.5 million in Q1 2025.

Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Steris' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$97.9 million for Q1 2026.

  • In Q1 2026, Cash from Financing Activities rose 45.03% year-over-year to -$97.9 million; the TTM figure through Mar 2026 stood at -$568.2 million (up 63.86% YoY), while the FY2026 annual figure was -$568.2 million, up 63.86% from the prior year.
  • Cash from Financing Activities was -$97.9 million for Q1 2026 at Steris, roughly flat from -$98.0 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $470.2 million in Q3 2023 to a low of -$998.9 million in Q2 2024.
  • Historically, Cash from Financing Activities has averaged -$176.4 million across 5 years, with a median of -$178.1 million in 2025.
  • The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 1146.13% in 2023, then plunged 367.57% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at -$120.4 million in 2022, then plunged by 64.43% to -$198.0 million in 2023, then declined by 8.29% to -$214.4 million in 2024, then surged by 54.29% to -$98.0 million in 2025, then rose by 0.1% to -$97.9 million in 2026.
  • The last three Cash from Financing Activities figures came in at -$97.9 million (Q1 2026), -$98.0 million (Q4 2025), and -$159.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 17.31 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -1.51 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -2.09 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -451.20 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -26.93 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -25.00 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 21.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -97.90 Mn
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -369.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -97.90 Mn
Mar 31, 2026 -97.90 Mn
Dec 31, 2025 -98.00 Mn
Dec 31, 2025 -98.00 Mn
Sep 30, 2025 -159.20 Mn
Sep 30, 2025 -159.20 Mn
Jun 30, 2025 -213.10 Mn
Jun 30, 2025 -213.10 Mn
Mar 31, 2025 -178.10 Mn
Mar 31, 2025 -178.10 Mn
Dec 31, 2024 -214.40 Mn
Dec 31, 2024 -214.40 Mn
Sep 30, 2024 -181.00 Mn
Sep 30, 2024 -181.00 Mn
Jun 30, 2024 -998.90 Mn
Jun 30, 2024 -998.90 Mn
Mar 31, 2024 -143.78 Mn
Mar 31, 2024 -143.78 Mn
Dec 31, 2023 -197.99 Mn
Dec 31, 2023 -197.99 Mn